QIAGEN Aarhus was founded in 2005 and has specialized in software tools for Next Generation Sequencing (NGS) analysis. We have a customer base of more than 50,000 active users, a global and highly skilled sales team, and a professional ISO-certified quality software development setup.
The CLC Genomics Workbench and CLC Microbial Genomics Module, produced by QIAGEN Aarhus, are a world leading software suite for NGS analysis of bacterial sequences, including de novo mapping, typing and metagenomics capabilities. The microbial NGS analysis business area is the largest and fastest growing area of CLC bio tools, currently experiencing a fundamental transition from R&D to professional software for biotechnology, food safety, disease outbreak monitoring and clinical applications.
Qiagen integrates a unique combination of expertise in computer science, high-performance computing, bioinformatics, NGS data analysis, statistics, gene expression, and molecular biology for developing highly advanced data analysis software for many different types of omics data and embedded in a user friendly interface ensuring a wide usage by industrial end users.
Qiagen will lead WP7 and move FindingPheno-developed technology from TRL4 to TRL6.